Pemphigoid was not associated with increased risk of solid organ, hematologic, or nonmelanoma skin malignancies in a nationally representative matched cohort

Clicks: 3
ID: 321475
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #168 of 176 articles by views in clinical and experimental dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 176 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The association between pemphigoid and malignancy remains controversial. In a national matched case-control analysis of the NIH All of Us database, encompassing 249 pemphigoid patients and 1,238 matched controls, we found no significant increase in hematologic, solid organ, or nonmelanoma skin cancer risk among patients with pemphigoid. These findings suggest that routine enhanced cancer screening beyond standard age-appropriate recommendations may not be warranted solely because of pemphigoid.
Reference Key
openalex_W7169621403 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Gaurav N. Pathak, Aalia Syed, Suraj S. Pathak, Brandon Tan, Dédée F. Murrell
Journal clinical and experimental dermatology
Year 2026
DOI
10.1093/ced/llag312
URL
https://doi.org/10.1093/ced/llag312
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.